Log in to save to my catalogue

Real-world outcomes of concomitant antidepressant and statin use in primary care patients with depre...

Real-world outcomes of concomitant antidepressant and statin use in primary care patients with depre...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cc60bcfd950d4124aebf26c8aed665c4

Real-world outcomes of concomitant antidepressant and statin use in primary care patients with depression: a population-based cohort study

About this item

Full title

Real-world outcomes of concomitant antidepressant and statin use in primary care patients with depression: a population-based cohort study

Publisher

England: BioMed Central Ltd

Journal title

BMC medicine, 2023-11, Vol.21 (1), p.424-424, Article 424

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Antidepressants are licensed for use in depressive disorders, but non-response and poor adherence to treatment affect a considerable number of patients. Pre-clinical and clinical evidence suggest that statins can augment the effects of antidepressants. However, the acceptability and tolerability of combining statins with antidepressants are unclear...

Alternative Titles

Full title

Real-world outcomes of concomitant antidepressant and statin use in primary care patients with depression: a population-based cohort study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_cc60bcfd950d4124aebf26c8aed665c4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cc60bcfd950d4124aebf26c8aed665c4

Other Identifiers

ISSN

1741-7015

E-ISSN

1741-7015

DOI

10.1186/s12916-023-03138-5

How to access this item